| Filed | Form | Description | |
|---|---|---|---|
| 3/6/26 | PRE 14A | PRE 14A | → |
| 3/12/25 | DEFA14A | DEFA14A | → |
| 3/12/25 | DEF 14A | DEF 14A | → |
| 2/26/25 | PRE 14A | PRE 14A | → |
| 3/13/24 | DEFA14A | DEFA14A | → |
| 3/13/24 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/10/26 | 4 | 4 | → |
| 2/26/26 | 4 | 4 | → |
| 2/25/26 | 4 | 4 | → |
| 2/19/26 | 4 | 4 | → |
| 2/19/26 | 4 | 4 | → |
| 2/19/26 | 4 | 4 | → |
| ↓ | |||
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments.